$VYCO
Vycor Medical Inc

2024 Q4 Form 10-Q Financial Statement

#000149315224045025 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $390.9K
YoY Change 26.66%
Cost Of Revenue $36.80K
YoY Change 13.8%
Gross Profit $354.1K
YoY Change 28.16%
Gross Profit Margin 90.59%
Selling, General & Admin $367.9K
YoY Change 31.33%
% of Gross Profit 103.91%
Research & Development $6.425K
YoY Change -11.38%
% of Gross Profit 1.81%
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $389.2K
YoY Change 28.98%
Operating Profit -$35.14K
YoY Change 37.89%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$24.64K
YoY Change -5.24%
Pretax Income -$59.77K
YoY Change 16.11%
Income Tax
% Of Pretax Income
Net Earnings -$59.82K
YoY Change 15.25%
Net Earnings / Revenue -15.3%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 33.37M shares 32.63M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $157.6K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $187.6K
Prepaid Expenses
Receivables $238.7K
Other Receivables
Total Short-Term Assets $743.4K
YoY Change 18.78%
LONG-TERM ASSETS
Property, Plant & Equipment $209.7K
YoY Change -19.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $331.2K
YoY Change -22.73%
TOTAL ASSETS
Total Short-Term Assets $743.4K
Total Long-Term Assets $331.2K
Total Assets $1.075M
YoY Change 1.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $151.0K
YoY Change 32.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.553M
YoY Change 12.94%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.553M
Total Long-Term Liabilities
Total Liabilities $4.758M
YoY Change 10.99%
SHAREHOLDERS EQUITY
Retained Earnings -$33.25M
YoY Change 1.58%
Common Stock $3.348K
YoY Change 2.29%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.033K
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity -$3.683M
YoY Change
Total Liabilities & Shareholders Equity $1.075M
YoY Change 1.91%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$59.82K
YoY Change 15.25%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
us-gaap Gross Profit
GrossProfit
1049425 usd
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 320
dei Entity Address City Or Town
EntityAddressCityOrTown
Boca Raton
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33487
dei City Area Code
CityAreaCode
(561)
dei Local Phone Number
LocalPhoneNumber
558-2020
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
VYCO
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
970 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
209732 usd
CY2024Q3 us-gaap Security Deposit
SecurityDeposit
6000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115442 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
47178 usd
CY2024Q3 VYCO Liabilities Of Disposal Groups Including Discontinued Operation Current
LiabilitiesOfDisposalGroupsIncludingDiscontinuedOperationCurrent
-672 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64745 usd
CY2024Q3 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
140316 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3348 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29431958 usd
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1033 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
127677 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3683346 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
usd
CY2023Q4 us-gaap Security Deposit
SecurityDeposit
6000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
149804 usd
CY2024Q3 VYCO Intangible And Other Asset Total
IntangibleAndOtherAssetTotal
121442 usd
CY2023Q4 VYCO Intangible And Other Asset Total
IntangibleAndOtherAssetTotal
155804 usd
CY2024Q3 us-gaap Assets
Assets
1074604 usd
CY2023Q4 us-gaap Assets
Assets
992298 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
150980 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
117801 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45321 usd
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33476130 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32732169 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33372796 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
32628835 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
3273 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
29365070 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
103334 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
103334 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1033 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33245323 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32820490 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
127677 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3325476 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
992298 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
308593 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1134098 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1152355 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36796 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
108965 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
102930 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
354056 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
276259 usd
us-gaap Gross Profit
GrossProfit
1025133 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6425 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
280113 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1000293 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
881744 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
389191 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
301740 usd
us-gaap Operating Expenses
OperatingExpenses
1053622 usd
us-gaap Operating Expenses
OperatingExpenses
945178 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35135 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25481 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28489 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
104247 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6002 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-103 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-78 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-252 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-209 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-24635 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-25998 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-71777 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-77366 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-59770 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-51479 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-100266 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
26881 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-59770 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-51479 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-100266 usd
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
26881 usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-47 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-425 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-197 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3517 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-59817 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-51904 usd
us-gaap Net Income Loss
NetIncomeLoss
-100463 usd
us-gaap Net Income Loss
NetIncomeLoss
23364 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
324370 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
324370 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-214089 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-424833 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-301006 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-2 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-59817 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51904 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-100463 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
23366 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2024Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2023Q3 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.01
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.00
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.00
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.00
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare
-0.00
us-gaap Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share
DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare
-0.00
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32903493 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32628835 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32721056 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
32595320 shares
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001424768
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
us-gaap Disposal Group Including Discontinued Operation Revenue
DisposalGroupIncludingDiscontinuedOperationRevenue
usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
usd
us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
usd
us-gaap Disposal Group Including Discontinued Operation Costs Of Goods Sold
DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold
usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
usd
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
usd
us-gaap Disposal Group Including Discontinued Operation Gross Profit Loss
DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss
usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses
DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses
DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
usd
us-gaap Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses
DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
usd
CY2024Q3 VYCO Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
usd
CY2023Q3 VYCO Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
usd
VYCO Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
usd
CY2024Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
CY2023Q3 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
VYCOR MEDICAL, INC.
dei Entity File Number
EntityFileNumber
001-34932
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3369218
dei Entity Address Address Line1
EntityAddressAddressLine1
951 Broken Sound Parkway
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33372796 shares
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.0001
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157633 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57291 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
238700 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
215231 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
187627 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
234145 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
158500 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
76684 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
739 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
743430 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
584090 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
252404 usd
CY2023Q4 VYCO Liabilities Of Disposal Groups Including Discontinued Operation Current
LiabilitiesOfDisposalGroupsIncludingDiscontinuedOperationCurrent
-1100 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4552889 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4074487 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100379 usd
CY2023Q4 us-gaap Long Term Loans From Bank
LongTermLoansFromBank
142908 usd
CY2024Q3 us-gaap Liabilities
Liabilities
4757950 usd
CY2023Q4 us-gaap Liabilities
Liabilities
4317774 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1074604 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
390852 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32334 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7250 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8688 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20308 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14880 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
14377 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
44641 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
43126 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
367886 usd
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
1458 usd
CY2024Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
162185 usd
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
162185 usd
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-222002 usd
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.01
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-3528307 usd
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73257 usd
CY2024Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6294 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-59817 usd
CY2024Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
162185 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3683346 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3325476 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3325476 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
73257 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6294 usd
us-gaap Net Income Loss
NetIncomeLoss
-100463 usd
us-gaap Net Income Loss
NetIncomeLoss
-100463 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
324370 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3683346 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-3683346 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-3018332 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-51904 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
162185 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3232421 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2940871 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2940871 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9454 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
2 usd
us-gaap Net Income Loss
NetIncomeLoss
23364 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
324370 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3232421 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-3232421 usd
us-gaap Net Income Loss
NetIncomeLoss
-100463 usd
us-gaap Net Income Loss
NetIncomeLoss
23364 usd
us-gaap Depreciation
Depreciation
47041 usd
us-gaap Depreciation
Depreciation
45650 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3375 usd
us-gaap Share Based Compensation
ShareBasedCompensation
8469 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7777 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
26844 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
99062 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-46518 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-44135 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
22737 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
15519 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
37443 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
37080 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
36034 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
35901 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
33179 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-86315 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
36179 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
29996 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
197 usd
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
915 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
98391 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
23922 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4369 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3482 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4369 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3482 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
60980 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
64786 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
54660 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
53208 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6320 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11578 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
100342 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32020 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
57291 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37035 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
157633 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
69055 usd
us-gaap Interest Paid Net
InterestPaidNet
4050 usd
us-gaap Interest Paid Net
InterestPaidNet
4176 usd
VYCO Noncash Accrued Dividends
NoncashAccruedDividends
324370 usd
VYCO Noncash Accrued Dividends
NoncashAccruedDividends
324370 usd
us-gaap Stock Issued1
StockIssued1
67152 usd
us-gaap Stock Issued1
StockIssued1
4727 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_80A_eus-gaap--BasisOfAccounting_z7mp8twzq2F7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1. <span id="xdx_829_zrYz8DfAmRjc">BASIS OF PRESENTATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements of Vycor Medical, Inc. (the “Company” or “Vycor”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the Securities Exchange Commission. In accordance with those rules and regulations certain information and footnote disclosures normally included in consolidated financial statements have been omitted pursuant to such rules and regulations. The consolidated balance sheet as of December 31, 2023 derives from the audited financial statements at that date, but does not include all the information and footnotes required by GAAP. These unaudited consolidated financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited consolidated financial statements as of and for the three and nine months ended September 30, 2024 and 2023, in the opinion of management, include all adjustments, consisting only of normal recurring adjustments, necessary for a fair presentation of the Company’s financial condition, results of operations and cash flows. The results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for any other interim period or for the entire year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ability to continue as a Going Concern</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared assuming that the Company will continue as a going concern. The Company has incurred losses since its inception, including a net loss of $<span id="xdx_909_eus-gaap--NetIncomeLoss_iN_di_c20240101__20240930_zw7M8dpKxud9" title="Net loss">100,463</span> for the nine months ended September 30, 2024 and has not generated sufficient positive cash flows from operations. As of September 30, 2024 the Company had a working capital deficiency of $<span id="xdx_907_ecustom--WorkingCapitalDeficit_iI_pp0p0_c20240930_zxxweNXW8V8i" title="Working capital deficit">3,809,459</span> which includes related party liabilities of $<span id="xdx_90B_eus-gaap--OtherLiabilities_iI_c20240930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_zcCIm02bOsi7" title="Related party liabilities">3,321,298</span>. These conditions, among others, raise substantial doubt regarding our ability to continue as a going concern. The unaudited consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classification of liabilities that may result from the outcome of this uncertainty.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is executing on a plan to achieve a reduction in cash operating losses. Included within the working capital deficiency above is a term note for $<span id="xdx_900_ecustom--WorkingCapitalDeficiencyIncludingDebtNote_iI_c20240930__dei--LegalEntityAxis__custom--EuroAmericanInvestmentCorpMember_zHSxxwLNle54" title="Working capital deficiency including term note">300,000</span> to EuroAmerican Investment Corp. (“EuroAmerican”), together with accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrentAndNoncurrent_iI_c20240930__dei--LegalEntityAxis__custom--EuroAmericanInvestmentCorpMember_zmPr7AEqhKz9" title="Accrued interest">508,931</span>, which has a maturity date of <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDate_dd_c20240101__20240930__dei--LegalEntityAxis__custom--EuroAmericanInvestmentCorpMember_zgTrtZ7Xh5kd" title="Maturity date">March 31, 2025</span>, having been extended on a number of occasions from its initial due date of June 11, 2011. At this time, it is not known whether any further extension of the note beyond March 31, 2025 will be available. However, the Company believes it may not have sufficient cash to meet its various cash needs through November 30, 2025 unless the Company is able to obtain additional cash from the issuance of debt or equity securities. Fountainhead, the Company’s largest shareholder, has provided working capital funding to the Company on an as-needed basis, although there is no guarantee that this will continue to be the case. The Company may consider seeking additional equity or debt funding, although there is no assurance that this would be available on acceptable terms or at all. If adequate funds are not available, the Company may have to delay or curtail development or commercialization of products, or cease some of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Net Income Loss
NetIncomeLoss
-100463 usd
CY2024Q3 VYCO Working Capital Deficit
WorkingCapitalDeficit
3809459 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5124104 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4894900 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5124104 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4894900 shares
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_84C_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zhneodScOXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_z1UgyFXDMOSi">Reclassifications</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain prior period amounts have been reclassified to conform with the current period presentation; on the cash flow statement, proceeds from and repayments of insurance financing has been separated out rather than being netted off; on the statements of stockholders’ deficiency, net income (loss) for the period and preferred stock dividends have been separated out rather than being combined.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></p>
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
970 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Cash And Cash Equivalents
DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
739 usd
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
970 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
739 usd
CY2024Q3 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
970 usd
CY2023Q4 us-gaap Assets Of Disposal Group Including Discontinued Operation
AssetsOfDisposalGroupIncludingDiscontinuedOperation
739 usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Accounts Payable Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
4 usd
CY2023Q4 us-gaap Disposal Group Including Discontinued Operation Accounts Payable Current
DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent
4 usd
CY2024Q3 VYCO Disposal Group Including Discontinued Operations Other Current Liabilities
DisposalGroupIncludingDiscontinuedOperationsOtherCurrentLiabilities
-676 usd
CY2023Q4 VYCO Disposal Group Including Discontinued Operations Other Current Liabilities
DisposalGroupIncludingDiscontinuedOperationsOtherCurrentLiabilities
-1104 usd
CY2024Q3 VYCO Liabilities Of Disposal Groups Including Discontinued Operation Current
LiabilitiesOfDisposalGroupsIncludingDiscontinuedOperationCurrent
-672 usd
CY2023Q4 VYCO Liabilities Of Disposal Groups Including Discontinued Operation Current
LiabilitiesOfDisposalGroupsIncludingDiscontinuedOperationCurrent
-1100 usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
47 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
425 usd
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
197 usd
us-gaap Disposal Group Including Discontinued Operation General And Administrative Expense
DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense
3365 usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
47 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
425 usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
197 usd
us-gaap Disposal Group Including Discontinued Operation Operating Expense
DisposalGroupIncludingDiscontinuedOperationOperatingExpense
3365 usd
CY2024Q3 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-47 usd
CY2023Q3 us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-425 usd
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-197 usd
us-gaap Disposal Group Including Discontinued Operation Operating Income Loss
DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
-3365 usd
us-gaap Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses
DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses
-152 usd
VYCO Disposal Group Including Discontinued Operation Other Income Expense
DisposalGroupIncludingDiscontinuedOperationOtherIncomeExpense
-152 usd
CY2024Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-47 usd
CY2023Q3 us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-425 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-197 usd
us-gaap Discontinued Operation Income Loss From Discontinued Operation Before Income Tax
DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
-3517 usd
CY2024Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-47 usd
CY2023Q3 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-425 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-197 usd
us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-3517 usd
CY2024Q3 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
337179 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
328267 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
140316 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
142908 usd
CY2024Q3 VYCO Inventory Raw Materials And Work In Process
InventoryRawMaterialsAndWorkInProcess
79319 usd
CY2023Q4 VYCO Inventory Raw Materials And Work In Process
InventoryRawMaterialsAndWorkInProcess
88236 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
108308 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
145909 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
187627 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
234145 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115442 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
149804 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
47178 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
45321 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64745 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
100379 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
111923 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
145700 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
390852 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
308593 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1134098 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1152355 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
354056 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
276259 usd
us-gaap Gross Profit
GrossProfit
1025133 usd
us-gaap Gross Profit
GrossProfit
1049425 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35135 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25481 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28489 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
104247 usd
CY2024Q3 us-gaap Assets
Assets
1074604 usd
CY2023Q4 us-gaap Assets
Assets
992298 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
390852 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
308593 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1134098 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1152355 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
354056 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
276259 usd
us-gaap Gross Profit
GrossProfit
1025133 usd
us-gaap Gross Profit
GrossProfit
1049425 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-35135 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-25481 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-28489 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
104247 usd
CY2024Q3 us-gaap Assets
Assets
1074604 usd
CY2023Q4 us-gaap Assets
Assets
992298 usd
CY2024Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
162185 usd
CY2023Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
162185 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
324370 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
324370 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
55000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Payments For Rent
PaymentsForRent
62856 usd
us-gaap Payments For Rent
PaymentsForRent
53535 usd
CY2024Q3 us-gaap Payments For Rent
PaymentsForRent
20535 usd
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
16362 usd
CY2012Q2 VYCO Sales And Excise Tax Payable Reduction Current And Noncurrent
SalesAndExciseTaxPayableReductionCurrentAndNoncurrent
75000 eur
CY2012Q2 VYCO Sales And Excise Tax Payable Reduction Current And Noncurrent
SalesAndExciseTaxPayableReductionCurrentAndNoncurrent
82000 usd
CY2012Q2 us-gaap Interest Expense
InterestExpense
12000 eur
CY2012Q2 us-gaap Interest Expense
InterestExpense
13200 usd
CY2016Q4 VYCO Sales And Excise Tax Payable Reduction Current And Noncurrent
SalesAndExciseTaxPayableReductionCurrentAndNoncurrent
75000 eur
CY2016Q4 VYCO Sales And Excise Tax Payable Reduction Current And Noncurrent
SalesAndExciseTaxPayableReductionCurrentAndNoncurrent
82000 usd
CY2016Q4 us-gaap Interest Expense
InterestExpense
12000 eur
CY2016Q4 us-gaap Interest Expense
InterestExpense
13200 usd
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2364 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2363 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7777 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
324370 usd
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
324370 usd
us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2594960 usd
CY2023 us-gaap Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
2270590 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
37443 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
37080 usd
CY2024Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
12571 usd
CY2023Q3 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
12436 usd

Files In Submission

Name View Source Status
0001493152-24-045025-index-headers.html Edgar Link pending
0001493152-24-045025-index.html Edgar Link pending
0001493152-24-045025.txt Edgar Link pending
0001493152-24-045025-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vyco-20240930.xsd Edgar Link pending
vyco-20240930_cal.xml Edgar Link unprocessable
vyco-20240930_def.xml Edgar Link unprocessable
vyco-20240930_lab.xml Edgar Link unprocessable
vyco-20240930_pre.xml Edgar Link unprocessable